Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

686 ARTÍCULOS , VIENDO DEL 241 AL 255

Neuropsychological Performance in Alzheimer's Disease versus Late-Life Depression: A Systematic Review and Meta-Analysis

Barlet BD, Hauson AO, Pollard AA, Zhang EZ, Nemanim NM, Sarkissians S, Lackey NS, Stelmach NP, Walker AD, Carson BT, Flora-Tostado C, Reszegi K, Allen KE, Viglione DJ.

Arch Clin Neuropsychol. 2023 Oct 20;38(7):991-1016. doi: 10.1093/arclin/acad036.

The LEISURE Study: A Longitudinal Randomized Controlled Trial Protocol for a Multi-Modal Lifestyle Intervention Study to Reduce Dementia Risk in Healthy Older Adults

Treacy C, Levenstein JM, Jefferies A, Metse AP, Schaumberg MA, Villani A, Boucas AP, Hermens DF, Lagopoulos J, Andrews SC.

J Alzheimers Dis. 2023;94(2):841-856. doi: 10.3233/JAD-230193.

Investigating the associations between upper limb motor function and cognitive impairment: a scoping review

Rudd KD, Lawler K, Callisaya ML, Alty J.

Geroscience. 2023 Dec;45(6):3449-3473. doi: 10.1007/s11357-023-00844-z. Epub 2023 Jun 20.

Does Cognitive Impairment Impact Motor Learning? A Scoping Review of Elderly Individuals With Alzheimer's Disease and Mild Cognitive Impairment

Palma GCS, Freitas TB, Bonuzzi GMG, Torriani-Pasin C.

Percept Mot Skills. 2023 Oct;130(5):1924-1951. doi: 10.1177/00315125231182732. Epub 2023 Jun 19.

A single-blind, parallel-group randomised trial of a Technology-assisted and remotely delivered Cognitive Behavioural Therapy intervention (Tech-CBT) versus usual care to reduce anxiety in people with mild cognitive impairment and dementia: study protocol for a randomised trial

Dissanayaka N, Brooks D, Worthy P, Mitchell L, Pachana NA, Byrne G, Keramat SA, Comans T, Bennett S, Liddle J, Chatfield MD, Broome A, Oram J, Appadurai K, Beattie E, Au T, King T, Welsh K, Pietsch A.

Trials. 2023 Jun 20;24(1):420. doi: 10.1186/s13063-023-07381-2.

Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System

Dávila G, Torres-Prioris MJ, López-Barroso D, Berthier ML.

CNS Drugs. 2023 Jul;37(7):599-637. doi: 10.1007/s40263-023-01017-4. Epub 2023 Jun 21.

Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspective

Elahi FM, Alladi S, Black SE, Claassen JAHR, DeCarli C, Hughes TM, Moonen J, Pajewski NM, Price BR, Satizabal C, Shaaban CE, Silva NCBS, Snyder HM, Sveikata L, Williamson JD, Wolters FJ, Hainsworth AH.

Cell Rep Med. 2023 Jun 20;4(6):101089. doi: 10.1016/j.xcrm.2023.101089.

Suspected Undiagnosed ADRD Among Middle Eastern and North African Americans

Kindratt TB, Ajrouch KJ, Zahodne LB, Dallo FJ.

J Immigr Minor Health. 2023 Oct;25(5):1098-1107. doi: 10.1007/s10903-023-01509-x. Epub 2023 Jun 23.

Differential response to donepezil in MRI subtypes of mild cognitive impairment

Diaz-Galvan P, Lorenzon G, Mohanty R, Mårtensson G, Cavedo E, Lista S, Vergallo A, Kantarci K, Hampel H, Dubois B, Grothe MJ, Ferreira D, Westman E.

Alzheimers Res Ther. 2023 Jun 23;15(1):117. doi: 10.1186/s13195-023-01253-2.

Alcohol Use Disorder as a Risk Factor for Cognitive Impairment

Wang G, Li DY, Vance DE, Li W.

J Alzheimers Dis. 2023;94(3):899-907. doi: 10.3233/JAD-230181.

Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders

Panza F, Solfrizzi V, Sardone R, Dibello V, Castellana F, Zupo R, Stallone R, Lampignano L, Bortone I, Mollica A, Berardino G, Ruan Q, Altamura M, Bellomo A, Daniele A, Lozupone M.

J Alzheimers Dis. 2023;94(3):879-898. doi: 10.3233/JAD-230312.

A promising tool to explore functional impairment in neurodegeneration: A systematic review of near-infrared spectroscopy in dementia

Butters E, Srinivasan S, O'Brien JT, Su L, Bale G.

Ageing Res Rev. 2023 Sep;90:101992. doi: 10.1016/j.arr.2023.101992. Epub 2023 Jun 24.

Adult Renal Dysfunction and Risk of Dementia or Cognitive Decline: Brain-Kidney Axis Hypothesis Based on a Systematic Review and Meta-Analysis

Chi HC, Liu Y, Tan CC, Zhang YC, Tan L, Xu W.

J Prev Alzheimers Dis. 2023;10(3):443-452. doi: 10.14283/jpad.2023.35.

Caffeine for Prevention of Alzheimer's Disease: Is the A(2A) Adenosine Receptor Its Target?

Merighi S, Travagli A, Nigro M, Pasquini S, Cappello M, Contri C, Varani K, Vincenzi F, Borea PA, Gessi S.

Biomolecules. 2023 Jun 8;13(6):967. doi: 10.3390/biom13060967.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias